Shifting paradigms & advancing technology to find I–O biomarkers

Abigail Pinchbeck, Assistant Editor, BioInsights, speaks to Mustafa Khasraw, Deputy Director of the Center for Cancer Immunotherapy, Duke Cancer Institute

Mustafa Khasraw MD, is a professor of medicine and neuro-oncology and Deputy Director of the Center for Cancer Immunotherapy at Duke University, USA. He is leading several clinical and translational programs with significant laboratory collaborations and is the principal investigator on first-in-human Phase I immunotherapy clinical trials in solid tumors with a special interest in CNS cancers.

The discovery of relevant biomarkers in immuno-oncology is crucial to match the right patients to the right treatments. In this interview, Mustafa Khasraw, Deputy Director of the Center for Cancer Immunotherapy at the Duke Cancer Institute, highlights the current challenges in this space – and potential approaches to overcome them.

Please enter your email to access content Read now